PERSPECTA

News from every angle

← Back to headlines

Cytokinetics CEO Robert Blum Sells 7,500 Shares

Cytokinetics CEO Robert Blum has sold 7,500 shares of the company's stock for a total of $575,700 in an insider transaction.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

YahooFrench14h ago

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700

Read full article →

Related Stories

Over 800,000 Central Government Posts Vacant in India

1h ago

Montenegro Waived €8.6 Million in Import VAT for Energy Projects

2h ago

Study Finds India's Rocket Launches Costliest Among Major Space Powers

2h ago

India Aims for Global Recognition with Lakadong Turmeric and GIFT City

2h ago